Related Experiment Video
Updated: Jan 6, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Hereditary Tyrosinemia Type 1: Success and Challenges in Indian Subcontinent
Samannay Das1, Vikrant Sood2, Bikrant Bihari Lal1
1Institute of Liver and Biliary Sciences, Department of Pediatric Hepatology, New Delhi, India.
Insights
Hereditary tyrosinemia type 1 (HT-1) outcomes in Indian children are poor, with high rates of cirrhosis and hepatocellular carcinoma (HCC). Liver transplantation is crucial for survival in these patients.
Area of Science:
- Pediatric Hepatology
- Metabolic Disorders
- Genetics
Background:
- Hereditary tyrosinemia type 1 (HT-1) is a rare genetic disorder affecting liver function.
- Early diagnosis and treatment are critical for managing HT-1.
- Limited data exists on HT-1 outcomes in the Indian subcontinent.
Purpose of the Study:
- To analyze the clinical profile and treatment outcomes of Indian children diagnosed with hereditary tyrosinemia type 1 (HT-1).
- To evaluate the impact of nitisinone (NTBC) treatment and liver transplantation on patient survival and disease progression.
Main Methods:
- Retrospective analysis of data from children with confirmed HT-1 diagnosis between 2013 and 2024.
- Inclusion of patients admitted to a pediatric hepatology unit at a tertiary care center.
- Comparison of outcomes between children treated with NTBC and those not receiving it.
Main Results:
- Eighteen children with HT-1 were analyzed, all presenting with established cirrhosis.
- Hepatocellular carcinoma (HCC) was present at diagnosis in 4 patients and developed in 4 others during follow-up.
- Only 38.9% of children received nitisinone (NTBC); outcomes were poor in the non-NTBC group, with 4 liver transplants and the rest dying.
Conclusions:
- Native liver outcomes for HT-1 in India are dismal, characterized by a high incidence of HCC.
- Liver transplantation (LT) is essential for achieving optimal outcomes in Indian children with HT-1.
- Post-LT survival was 100%, with no new-onset or recurrent HCC, highlighting its efficacy.
Objectives:
To analyze the profile and outcomes of Indian children with hereditary tyrosinemia type 1 (HT-1).
Methods:
In this retrospective study, the data of children with a confirmed diagnosis of HT-1 from 2013 to 2024 admitted in the pediatric hepatology unit of a tertiary care referral center were analyzed.
Results:
Eighteen children with HT-1 with a median (Q1, Q3) age of diagnosis of 15.5 (6, 44) months were included. All children had established cirrhosis. Hepatocellular carcinoma (HCC) was noted in 4 patients at baseline, while HCC developed in 4 children on follow-up. Only 7 (38.9%) children could be initiated on nitisinone or 2-[2-nitro-4-trifluoromethylbenzoyl]-1,3-cyclohexanedione (NTBC). In the NTBC group (n = 7), one child survived with native liver, 3 children underwent liver transplant (LT) and 3 died. In the non-NTBC group (n = 11), 4 underwent LT (rest died). Post-LT survival was 100% without new-onset/recurrent HCC.
Conclusion:
Native liver outcomes for HT-1 in the Indian subcontinent remain dismal with a high proportion developing HCC and requiring LT for optimum outcomes.
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
Gene Therapy
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Epistasis

